 |
A bridge from
Science to
Patient Care.
 |
 |
|

 |

Albert van der Vliet, Ph.D.  |
|
| |
|
Contact Information
|
|
|
Albert van der Vliet, Ph.D.
Associate Professor, Department of Pathology, College of Medicine, University of Vermont, Burlington, VT
Room C-226, Given Building University of Vermont, College of Medicine Burlington, VT 05405-0068
Voice: (802) 656-8638 Fax: (802) 656-8892
Email: avanderv@zoo.uvm.edu
|
| |
|
Training and Professional Experience
|
|
|
|
- B.S./M.S.(11/1987) Molecular Pharmacology and Analytical Chemistry, Vrije Universiteit, Amsterdam, The Netherlands
- Postgraduate (11/1989) Laboratory Animal Handling Techniques; Rijksuniversiteit Utrecht, Utrecht, The Netherlands.
- Ph.D. (6/1991) Pharmacochemistry, Vrije Universiteit, Amsterdam, The Netherlands.
- Postdoctoral Researcher(6/91 - 1/93), Department of Pharmacochemistry, Vrije Universiteit, Amsterdam, The Netherlands.
- Postdoctoral Researcher(2/93 - 4/97), Department of Internal Medicine, University of California, Davis.
- Visiting Scientist(5/95 - 8/95), Pharmacology Group, King's College, Chelsea Campus, University of London, U.K.
- Assistant Research Biochemist(5/97 – 6/99), Department of Internal Medicine, University of California, Davis.
- Assistant Professor in Residence(7/99 – 6/01), Department of Internal Medicine, University of California, Davis.
- Associate Professor in Residence(7/01 – 4/02), Department of Internal Medicine, University of California, Davis.
- Associate Professor(5/02 – present), Department of Pathology, College of Medicine, University of Vermont, Burlington, VT
|
| |
|
Research Interests
|
|
|
|
- Oxidative biochemistry of nitric oxide;
- Oxidant mechanisms in inflammation;
- Respiratory tract biology and pathology;
- Chemical mechanisms of protein oxidation;
- Signal transduction; Inhalation toxicology;
- Analysis of antioxidants and oxidation products in biomolecules (proteins, lipids, and nucleic acids);
- Antioxidant micronutrients.
|
| |
|
Selected Publications
|
|
|
|
- Determination of low-molecular mass antioxidant concentrations in human respiratory tract lining fluids. Am. J. Physiol. 276, L289-L296. A. van der Vliet, C.E. Cross, C.A. O'Neill, W.G. Volz, B. Halliwell, and S. Louie (1999)
- Reactive nitrogen species and tyrosine nitration in the respiratory tract: Epiphenominae or pathobiological mechanism of disease. Am. J. Respir. Crit. Care Med. 160, 1-9. A. van der Vliet, J.P. Eiserich, M.K. Shigenaga, and C.E. Cross (1999)
- Myeloperoxidase and protein oxidation in cystic fibrosis. Am. J. Physiol. 279, L537-L546. A. van der Vliet, M.N. Nguyen, M.K. Shigenaga, J.P. Eiserich, G.P. Marelich, and C.E. Cross (2000)
- Oxidants, nitrosants, and the lung. Am. J. Med. 109, 398-421. A. van der Vliet, and C.E. Cross (2000)
- Inhibition of neutrophil apoptosis by acrolein: A contributing factor in tobacco-related inflammatory lung disease? Am. J. Physiol. 281, L732-L739. Finkelstein, E.I., M. Nardini, and A. van der Vliet (2001)
- S-Nitrosothiols inhibit cytokine-mediated induction of MMP-9 in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 27, 463-473. T. Okamoto, G. Valacchi, K. Gohil, T. Akaike, and A. van der Vliet (2002)
- Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am. J. Physiol. 286, L198-L209. T. Okamoto, K. Gohil, E.I. Finkelstein, P. Bove, T. Akaike, and A. van der Vliet (2004)
|
 |
 |
 |
| |
|
|
 |
 |
 |
|